Advancement in the Development of Therapeutics Against Zika Virus Infection

Kangchen Li; Qianting Ji; Shibo Jiang; Naru Zhang

doi:10.3389/fcimb.2022.946957

Frontiers in Cellular and Infection Microbiology (Jul 2022)

Advancement in the Development of Therapeutics Against Zika Virus Infection

Kangchen Li,
Qianting Ji,
Shibo Jiang,
Naru Zhang

Affiliations

Kangchen Li: Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, China
Qianting Ji: Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, China
Shibo Jiang: Key Laboratory of Medical Molecular Virology of Ministry of Education (MOE), National Health Commission (NHC) and Chinese Academy of Medical Sciences (CAMS), School of Basic Medical Sciences and Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China
Naru Zhang: Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, China

DOI: https://doi.org/10.3389/fcimb.2022.946957
Journal volume & issue: Vol. 12

Abstract

Read online

Zika virus (ZIKV), a re-emerging arbovirus, causes teratogenic effects on the fetus and normal nerve functions, resulting in harmful autoimmune responses, which call for the development of therapeutics against ZIKV infection. In this review, we introduce the pathogenesis of ZIKV infection and summarize the advancement in the development of therapeutics against ZIKV infection. It provides guidance for the development of effective therapeutics against ZIKV infection.

Published in Frontiers in Cellular and Infection Microbiology

ISSN: 2235-2988 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Science: Microbiology
Website: http://www.frontiersin.org/Cellular-and-Infection-Microbiology

About the journal

Abstract

Keywords